BioXcel Therapeutics Inc - BTAI - stock price prediction, stock price target, analyst ratings from 4 analysts

BioXcel Therapeutics Inc has a share price target of US$ 14, revenue growth forecast of 20.3%, and profit growth estimate of 10.9% for FY26, based on top 4 analyst calls.